Cartesian Therapeutics, Inc. (RNAC)

NASDAQ: RNAC · IEX Real-Time Price · USD
0.660
+0.036 (5.80%)
At close: Mar 27, 2024, 4:00 PM
0.675
+0.015 (2.21%)
After-hours: Mar 27, 2024, 7:19 PM EDT

Total Valuation

RNAC has a market cap or net worth of $106.51 million. The enterprise value is $40.56 million.

Market Cap 106.51M
Enterprise Value 40.56M

Important Dates

The last earnings date was Thursday, March 7, 2024, before market open.

Earnings Date Mar 7, 2024
Ex-Dividend Date n/a

Share Statistics

RNAC has 161.95 million shares outstanding. The number of shares has increased by 6.33% in one year.

Shares Outstanding 161.95M
Shares Change (YoY) +6.33%
Shares Change (QoQ) +2.60%
Owned by Insiders (%) 30.65%
Owned by Institutions (%) 40.66%
Float 103.76M

Valuation Ratios

PE Ratio n/a
Forward PE 25.45
PS Ratio 4.10
Forward PS 6.96
PB Ratio n/a
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 1.56
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.33

Current Ratio 1.33
Quick Ratio 1.26
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -83.26

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -124.40%
Return on Capital (ROIC) n/a
Revenue Per Employee $702,811
Profits Per Employee -$5.94M
Employee Count 37
Asset Turnover 0.15
Inventory Turnover n/a

Taxes

Income Tax -19.00M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -50.35% in the last 52 weeks. The beta is 0.83, so RNAC's price volatility has been lower than the market average.

Beta (1Y) 0.83
52-Week Price Change -50.35%
50-Day Moving Average 0.70
200-Day Moving Average 0.96
Relative Strength Index (RSI) 48.33
Average Volume (30 Days) 674,142

Short Selling Information

The latest short interest is 8.30 million, so 5.13% of the outstanding shares have been sold short.

Short Interest 8.30M
Short Previous Month 6.52M
Short % of Shares Out 5.13%
Short % of Float 8.00%
Short Ratio (days to cover) 13.74

Income Statement

In the last 12 months, RNAC had revenue of $26.00 million and -$219.71 million in losses. Loss per share was -$1.66.

Revenue 26.00M
Gross Profit 26.00M
Operating Income -86.42M
Pretax Income -238.71M
Net Income -219.71M
EBITDA -233.28M
EBIT -235.88M
Loss Per Share -$1.66
Full Income Statement

Balance Sheet

The company has $76.91 million in cash and $10.96 million in debt, giving a net cash position of $65.96 million or $0.41 per share.

Cash & Cash Equivalents 76.91M
Total Debt 10.96M
Net Cash 65.96M
Net Cash Per Share $0.41
Equity / Book Value -440.18M
Book Value Per Share -2.72
Working Capital 22.52M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$51.16 million and capital expenditures -$206,000, giving a free cash flow of -$51.37 million.

Operating Cash Flow -51.16M
Capital Expenditures -206,000
Free Cash Flow -51.37M
FCF Per Share -$0.33
Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -332.32% and -844.91%.

Gross Margin 100.00%
Operating Margin -332.32%
Pretax Margin -917.97%
Profit Margin -844.91%
EBITDA Margin -897.09%
EBIT Margin -907.08%
FCF Margin -197.53%

Dividends & Yields

RNAC does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -6.33%
Shareholder Yield -6.33%
Earnings Yield -206.27%
FCF Yield -48.23%

Analyst Forecast

The average price target for RNAC is $2.00, which is 202.85% higher than the current price. The consensus rating is "Strong Buy".

Price Target $2.00
Price Target Difference 202.85%
Analyst Consensus Strong Buy
Analyst Count 1
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on December 1, 2023. It was a forward split with a ratio of 2:1.

Last Split Date Dec 1, 2023
Split Type Forward
Split Ratio 2:1

Scores

RNAC has an Altman Z-Score of -5.06 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -5.06
Piotroski F-Score 2